NCT04821674View on ClinicalTrials.gov

Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

August 13, 2021

Study Completion Date

July 14, 2022

Conditions
Covid19
Interventions
BIOLOGICAL

DS-5670a

DS-5670a (10, 30, 60 or 100 µg) administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total

BIOLOGICAL

Placebo

Placebo administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total

Trial Locations (1)

812-0025

SOUSEIKAI Hakata Clinic, Hakata

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY

NCT04821674 - Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects | Biotech Hunter | Biotech Hunter